Literature DB >> 2498955

The effects of scopolamine and clonidine upon the performance and learning of a motor skill.

C D Frith1, M A McGinty, I Gergel, T J Crow.   

Abstract

Twenty-eight subjects practised a task involving procedural knowledge in which a moving target has to be followed for two 3-min sessions. They were then randomly allocated to receive an IV injection of 0.4 mg scopolamine, 0.15 mg clonidine or saline. General impairment due to both active treatments was seen 20 min later in significantly decreased tracking performance. Subjects then had to learn a mirror-reversed version of the tracking task. This involved acquiring novel procedural knowledge. Subjects who had either saline or clonidine treatment showed rapid temporary improvements and also considerable permanent learning. Subjects treated with scopolamine, however, showed only slow temporary improvement and little permanent improvement in their performance at this task. This result suggests that a normally functioning cholinergic system is necessary not only for an efficient working memory but also for the long term acquisition of some kinds of procedural knowledge.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498955     DOI: 10.1007/bf00442017

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance.

Authors:  A C Parrott
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Impairments in the learning and performance of a new manual skill in patients with Parkinson's disease.

Authors:  C D Frith; C A Bloxham; K N Carpenter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-06       Impact factor: 10.154

3.  Neurochemical dissociation of memory systems.

Authors:  M J Nissen; D S Knopman; D L Schacter
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

4.  The effects of intravenous diazepam and hyoscine upon human memory.

Authors:  C D Frith; J T Richardson; M Samuel; T J Crow; P J McKenna
Journal:  Q J Exp Psychol A       Date:  1984-02

Review 5.  Functional studies of the central catecholamines.

Authors:  T W Robbins; B J Everitt
Journal:  Int Rev Neurobiol       Date:  1982       Impact factor: 3.230

6.  An inventory for the measurement of self-reported stress and arousal.

Authors:  C Mackay; T Cox; G Burrows; T Lazzerini
Journal:  Br J Soc Clin Psychol       Date:  1978-09

7.  Learning and reminiscence as a function of target predictability in a two-dimensional tracking task.

Authors:  C D Frith; R J Lang
Journal:  Q J Exp Psychol       Date:  1979-02       Impact factor: 2.143

8.  Qualitative analysis of scopolamine-induced amnesia.

Authors:  E D Caine; H Weingartner; C L Ludlow; E A Cudahy; S Wehry
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.

Authors:  D S Charney; G R Heninger; D E Redmond
Journal:  Life Sci       Date:  1983-07-04       Impact factor: 5.037

10.  Selective impairment of paired associate learning after administration of a centrally-acting adrenergic agonist (clonidine).

Authors:  C D Frith; J Dowdy; I N Ferrier; T J Crow
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more
  3 in total

1.  Effect of dexmedetomidine and midazolam on human performance and mood.

Authors:  M J Mattila; M E Mattila; K T Olkkola; H Scheinin
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  [Treatment of cognitive deficits in schizophrenia. Part 2: Pharmacological strategies].

Authors:  D Roesch-Ely; U Pfueller; C Mundt; U Müller; M Weisbrod
Journal:  Nervenarzt       Date:  2010-05       Impact factor: 1.214

3.  The neuropharmacology of implicit learning.

Authors:  Julia Uddén; Vasiliki Folia; Karl Magnus Petersson
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.